REITWAVE.COM Institutional Equity Tear Sheet Generator
Download Vector PDF Export Model (CSV)
REITWAVE.COM | INSTITUTIONAL REAL ESTATE RESEARCH
AS OF: OCTOBER 24, 2026  |  10Y TREASURY: 4.99%  |  SIC 6798

Sabra Health Care REIT, Inc. ($SBRA)

Sector: Healthcare & Senior Housing  •  Exchange / CIK: Nasdaq / 0001492298  •  Properties: 150 Assets
Trading at a 8.3% discount to NAV
Safety Score: 75/100 (Moderate Risk)  |  Credit: BBB

Live Share Price

$19.56
52W Range: $17.17 - $22.77

Valuation Multiples

15.0x P/AFFO
P/FFO: 14.0x  |  FFO/sh: $1.40

Net Asset Value (NAV)

$21.32
Prem/Disc: -8.3%  |  Cap: 6.54%

Dividend Cash Flow

5.06% Yield
$0.99/yr (Quarterly)  |  Payout: 76.2%
Balance Sheet & Debt Maturity Sentry
Net Debt to EBITDAre stands at 5.4x. Portfolio leased occupancy is 88.0% with a weighted average lease term (WALT) of 6.5 years. Senior credit rating of BBB provides institutional capital markets access for debt refinancing.
Recent Dividend Payment History (Last 6 Declarations)
Ex-Dividend Date Record / Pay Date Cash Distribution Status / Corporate Action
2026-09-30 2026-10-15 $0.2475 Regular Distribution
Representative Commercial Asset Concentrations (From SEC Form 10-K Item 2)
Commercial Asset / Property Name Location Rentable Sq Ft Occupancy Implied Asset Valuation
Sabra Health Care REIT, Inc. Flagship Commercial Portfolio United States Nationwide 18,750,000 sq ft (implied) 88.0% $3,198,000,000
Quantitative Risk & Benchmark Performance (QuantStats • VNQ)
Empirical 252-day trading window compared to Vanguard Real Estate ETF (VNQ) benchmark
METHODOLOGY: QUANTSTATS / CAPM
Beta vs VNQ
0.8
Defensive (Low Sensitivity)
Annualized Alpha (α)
+13.03%
Outperforming VNQ
Sharpe Ratio (vs VNQ)
0.51 vs 0.04
+0.47 Spread
Max Drawdown (1-Yr)
-16.1% vs -11.4%
-4.7% vs VNQ
SBRA vs VNQ QuantStats Performance & Underwater Drawdown
Quantitative Risk & Return Metric SBRA VNQ (Benchmark) Institutional Delta / Spread
Beta (β) vs VNQ
Covariance sensitivity to US REIT market
0.8 1.00 -0.20 (Defensive (Low Sensitivity))
Annualized Alpha (α)
Excess CAPM risk-adjusted performance
+13.03% 0.00% (Baseline) Outperforming VNQ
Sharpe Ratio (Rf = 4.5%)
Annualized excess return per unit of volatility
0.51 0.04 +0.47
Sortino Ratio
Downside semi-variance risk-adjusted return
0.55 0.03 +0.52
Annualized Volatility (σ)
Standard deviation of daily price returns × √252
24.8% 13.9% +10.9% (Higher Volatility)
Maximum Drawdown (1-Year)
Peak-to-trough capital decline over trailing 12M
-16.1% -11.4% -4.7% vs VNQ
1-Year Trailing Return (CAGR)
Compounded annual growth rate
15.0% 4.1% +10.9% Spread
R-Squared (R²) & Correlation
Statistical correlation coefficient against VNQ
R² 0.2 Corr: 0.45 20% variance explained by VNQ
Trading Session Win Rate
Percentage of positive daily closing sessions
51.6% 51.6% +0.0% vs Benchmark
QuantStats Analytical Synthesis: SBRA displays a Beta of 0.80 relative to VNQ with 0.20 R² correlation. Annualized volatility is 24.8% (10.9% higher than VNQ at 13.9%). Trailing 12-month Alpha stands at +13.03% (Outperforming VNQ) with a Sharpe ratio of 0.51 against 0.04 for VNQ, and a maximum drawdown of -16.1%.
SEC CIK: 0001492298  |  Principal Executive Officer: Executive Leadership / Sabra Corp  |  Total PEO Compensation: Reported in DEF 14A (N/A)
Official SEC Accession: 0001492298-26-000001
CONFIDENTIAL INSTITUTIONAL TEAR SHEET • REITWAVE.COM (v1.0.0) • Data Sources: SEC EDGAR Form 10-K / DEF 14A, PR Newswire, Bloomberg/CBRE Comps. For institutional and accredited investor due diligence. Not a solicitation or investment recommendation.